Identification | Back Directory | [Name]
2-Thiophenecarboxamide, 3-[[2-[[1-[2-(dimethylamino)acetyl]-1,2,3,4-tetrahydro-6-methoxy-4,4-dimethyl-7-quinolinyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]- | [CAS]
1123163-20-1 | [Synonyms]
GSK2163632A 2-Thiophenecarboxamide, 3-[[2-[[1-[2-(dimethylamino)acetyl]-1,2,3,4-tetrahydro-6-methoxy-4,4-dimethyl-7-quinolinyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]- | [Molecular Formula]
C27H32N8O3S | [MOL File]
1123163-20-1.mol | [Molecular Weight]
548.66 |
Hazard Information | Back Directory | [Description]
GSK2163632A is an insulin-like growth factor 1 receptor inhibitor. It acts by binding to a novel region of the GRK active site cleft that could likely be exploited to achieve more selectivity. |
|
|